These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 28861842)

  • 1. Myeloma and Bone Disease.
    Panaroni C; Yee AJ; Raje NS
    Curr Osteoporos Rep; 2017 Oct; 15(5):483-498. PubMed ID: 28861842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma bone disease: pathogenesis and treatment.
    O'Donnell EK; Raje NS
    Clin Adv Hematol Oncol; 2017 Apr; 15(4):285-295. PubMed ID: 28591104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evidence-Based Approach to Myeloma Bone Disease.
    Bingham N; Reale A; Spencer A
    Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of multiple myeloma-related bone disease].
    Jurczyszyn A; Grosicki S; Czerniuk MR; Morga R; Małecki K; Skotnicki AB
    Przegl Lek; 2013; 70(11):950-7. PubMed ID: 24697037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple myeloma].
    Abe M
    Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
    Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
    N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology and treatment of myeloma related bone disease.
    Terpos E; Christoulas D; Gavriatopoulou M
    Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.
    Ashcroft AJ; Davies FE; Morgan GJ
    Lancet Oncol; 2003 May; 4(5):284-92. PubMed ID: 12732166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.
    Terpos E; Dimopoulos MA; Berenson J
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S13-23. PubMed ID: 21353176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of myeloma bone disease.
    Roodman GD
    Leukemia; 2009 Mar; 23(3):435-41. PubMed ID: 19039321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biosphonates in oncology].
    Paule B; Clerc D; Brion N
    Presse Med; 2000 Apr; 29(13):723-9. PubMed ID: 10797827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the biology and treatment of bone disease in multiple myeloma.
    Raje N; Roodman GD
    Clin Cancer Res; 2011 Mar; 17(6):1278-86. PubMed ID: 21411443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma and bone disease: "the dangerous tango".
    Epstein J; Walker R
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):300-6. PubMed ID: 16728940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR; Lipton A
    Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metastases in lung cancer].
    Tsuya A; Fukuoka M
    Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging treatment approaches for myeloma-related bone disease.
    Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
    Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone lesion in multiple myeloma].
    Ise M; Takagi T
    Nihon Rinsho; 2007 Dec; 65(12):2224-8. PubMed ID: 18069264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease.
    Todoerti K; Lisignoli G; Storti P; Agnelli L; Novara F; Manferdini C; Codeluppi K; Colla S; Crugnola M; Abeltino M; Bolzoni M; Sgobba V; Facchini A; Lambertenghi-Deliliers G; Zuffardi O; Rizzoli V; Neri A; Giuliani N
    Exp Hematol; 2010 Feb; 38(2):141-53. PubMed ID: 19963035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma bone disease and treatment options.
    Yeh HS; Berenson JR
    Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.